Dimethyl Sulfoxide

Verify with FDA CVM →

20 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
20
Total Reports
3
Deaths Reported
1500.0%
Death Rate

Active Ingredients

Dimethyl Sulfoxide

Administration Routes

TopicalUnknownIntravenousOralAuricular (Otic)

Species Affected

Horse 10
Dog 6
Unknown 1
Human 1
Other 1
Cat 1

Most Affected Breeds

Thoroughbred 4
Bulldog 4
Horse (unknown) 3
Unknown 3
Crossbred Equine/horse 1
Warmblood (unspecified) 1
Retriever - Golden 1
Ragdoll 1
Quarter Horse 1
Bulldog - American 1

Most Reported Reactions

Ataxia 3
Cutaneous calcinosis 3
Bacterial skin infection NOS 2
Hind limb ataxia 2
Odor, Abnormal 2
Increased sweating 2
Lack of efficacy - NOS 2
Injection site swelling 2
Decreased urine concentration 2
Muscle stiffness 1
Lameness 1
Gait abnormality 1

Outcome Breakdown

Outcome Unknown
11 (57.9%)
Ongoing
4 (21.1%)
Died
2 (10.5%)
Euthanized
1 (5.3%)
Recovered with Sequela
1 (5.3%)

Data Summary

Metric Value
Total adverse event reports 20
Reports involving death 3
Case-fatality rate (reported events) 1500.0%
Distinct species in reports 6
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Dimethyl Sulfoxide Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 20 adverse event reports referencing Dimethyl Sulfoxide, including 3 reports in which the animal died — a 1500.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Dimethyl Sulfoxide. Reported administration routes include Topical, Unknown, Intravenous, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Dimethyl Sulfoxide reports are Horse (10 reports), Dog (6 reports), Unknown (1 reports), with Horse accounting for the largest share. Within those species, Thoroughbred (4), Bulldog (4), Horse (unknown) (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Dimethyl Sulfoxide are Ataxia (3), Cutaneous calcinosis (3), Bacterial skin infection NOS (2), Hind limb ataxia (2). Of the 19 reports with a coded outcome, Outcome Unknown is the leading category at 57.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Dimethyl Sulfoxide.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial